Advertisement
Advertisement

INFU

INFU logo

InfuSystem Holdings, Inc.

8.41
USD
Sponsored
-0.56
-6.24%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

8.72

+0.31
+3.73%

INFU Earnings Reports

Positive Surprise Ratio

INFU beat 14 of 24 last estimates.

58%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$37.48M
/
$0.11
Implied change from Q1 26 (Revenue/ EPS)
+11.27%
/
+120.00%
Implied change from Q2 25 (Revenue/ EPS)
+4.10%
/
-8.33%

InfuSystem Holdings, Inc. earnings per share and revenue

On May 07, 2026, INFU reported earnings of 0.05 USD per share (EPS) for Q1 26, beating the estimate of 0.03 USD, resulting in a 46.63% surprise. Revenue reached 33.68 million, compared to an expected 35.03 million, with a -3.86% difference. The market reacted with a +3.05% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of 0.11 USD, with revenue projected to reach 37.48 million USD, implying an increase of 120.00% EPS, and increase of 11.27% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
logo
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
logo
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
logo
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
logo
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
logo
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
logo
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
logo
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
logo
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
FAQ
For Q1 2026, InfuSystem Holdings, Inc. reported EPS of $0.05, beating estimates by 46.63%, and revenue of $33.68M, -3.86% below expectations.
The stock price moved up 3.05%, changed from $9.83 before the earnings release to $10.13 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 7 analysts, InfuSystem Holdings, Inc. is expected to report EPS of $0.11 and revenue of $37.48M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement